Your browser doesn't support javascript.
loading
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis.
Rodríguez, Alejandro H; Avilés-Jurado, Francesc X; Díaz, Emili; Schuetz, Philipp; Trefler, Sandra I; Solé-Violán, Jordi; Cordero, Lourdes; Vidaur, Loreto; Estella, Ángel; Pozo Laderas, Juan C; Socias, Lorenzo; Vergara, Juan C; Zaragoza, Rafael; Bonastre, Juan; Guerrero, José E; Suberviola, Borja; Cilloniz, Catia; Restrepo, Marcos I; Martín-Loeches, Ignacio.
Afiliación
  • Rodríguez AH; Critical Care Department, Hospital Universitari de Tarragona Joan XXIII, IISPV/URV/CIBERes, Tarragona, Spain. Electronic address: ahr1161@yahoo.es.
  • Avilés-Jurado FX; Otorhinolaryngology Head-Neck Surgery Department, Hospital Universitari de Tarragona Joan XXIII, IISPV/URV, Tarragona, Catalonia, Spain. Electronic address: fxavilesj@gmail.com.
  • Díaz E; Critical Care Department, ParcTaulí Hospital/CIBERes, Sabadell, Spain. Electronic address: emilio.diaz.santos@gmail.com.
  • Schuetz P; Internal Medicine Department, Kantonsspital Aarau, Switzerland. Electronic address: schuetzph@gmail.com.
  • Trefler SI; Critical Care Department, Hospital Universitari de Tarragona Joan XXIII, IISPV/URV/CIBERes, Tarragona, Spain. Electronic address: sitrefler@yahoo.es.
  • Solé-Violán J; Critical Care Department, Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain. Electronic address: jsolvio@gobiernodecanarias.org.
  • Cordero L; Critical Care Department, CHUAC, A Coruña, Spain. Electronic address: lcorlor@gmail.com.
  • Vidaur L; Critical Care Department, Hospital de Donostia, San Sebastian, Spain. Electronic address: loreto.vidaurtello@osakidetza.net.
  • Estella Á; Critical Care Department, Hospital SAS, Jerez de la Frontera, Spain. Electronic address: litoestella@hotmail.com.
  • Pozo Laderas JC; Critical Care Department, Hospital Reina Sofía, Córdoba, Spain. Electronic address: juanc.pozo.sspa@juntadeandalucia.es.
  • Socias L; Critical Care Department, Hospital Son Llatzer, Palma de Mallorca, Spain. Electronic address: lsocias3@gmail.com.
  • Vergara JC; Critical Care Department, Hospital de Cruces, Vizcaya, Spain. Electronic address: juancarlos.vergaraserrano@osakidetza.net.
  • Zaragoza R; Critical Care Department, Hospital Dr. Peset, Valencia, Spain. Electronic address: zaragozar@ono.com.
  • Bonastre J; Critical Care Department, Hospital La Fe, Valencia, Spain. Electronic address: bonastre_jua@gva.es.
  • Guerrero JE; Critical Care Department, Hospital Gregorio Marañón, Madrid, Spain. Electronic address: jeguerrerosanz@gmail.com.
  • Suberviola B; Critical Care Department, Hospital Universitario de Santander, Spain. Electronic address: borja.suberviola@gmail.com.
  • Cilloniz C; Critical Care Department, Hospital Clinic / CIBERES, Barcelona, Spain. Electronic address: catiacilloniz@yahoo.com.
  • Restrepo MI; Division of Pulmonary Diseases and Critical Care Medicine, University of Texas Health Science Center at San Antonio San Antonio, TX, USA. Electronic address: restrepom@uthscsa.edu.
  • Martín-Loeches I; Multidisciplinary Intensive Care Research Organization (MICRO), Department of Anaesthesia and Critical Care, St James's University Hospital, Trinity Centre for Health Sciences, Dublin, Ireland. Electronic address: drmartinloeches@gmail.com.
J Infect ; 72(2): 143-51, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26702737
ABSTRACT

OBJECTIVES:

To define which variables upon ICU admission could be related to the presence of coinfection using CHAID (Chi-squared Automatic Interaction Detection) analysis.

METHODS:

A secondary analysis from a prospective, multicentre, observational study (2009-2014) in ICU patients with confirmed A(H1N1)pdm09 infection. We assessed the potential of biomarkers and clinical variables upon admission to the ICU for coinfection diagnosis using CHAID analysis. Performance of cut-off points obtained was determined on the basis of the binominal distributions of the true (+) and true (-) results.

RESULTS:

Of the 972 patients included, 196 (20.3%) had coinfection. Procalcitonin (PCT; ng/mL 2.4 vs. 0.5, p < 0.001), but not C-reactive protein (CRP; mg/dL 25 vs. 38.5; p = 0.62) was higher in patients with coinfection. In CHAID analyses, PCT was the most important variable for coinfection. PCT <0.29 ng/mL showed high sensitivity (Se = 88.2%), low Sp (33.2%) and high negative predictive value (NPV = 91.9%). The absence of shock improved classification capacity. Thus, for PCT <0.29 ng/mL, the Se was 84%, the Sp 43% and an NPV of 94% with a post-test probability of coinfection of only 6%.

CONCLUSION:

PCT has a high negative predictive value (94%) and lower PCT levels seems to be a good tool for excluding coinfection, particularly for patients without shock.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Precursores de Proteínas / Infecciones Bacterianas / Calcitonina / Gripe Humana / Coinfección Tipo de estudio: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Precursores de Proteínas / Infecciones Bacterianas / Calcitonina / Gripe Humana / Coinfección Tipo de estudio: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Infect Año: 2016 Tipo del documento: Article